Business

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtainment of CEP Certificate for Sodium Valproate API by Holding Subsidiary China Resources Double-Crane Pharmaceutical (Hunan) Co., Ltd.

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtainment of CEP Certificate for Sodium Valproate API by Holding Subsidiary China Resources Double-Crane Pharmaceutical (Hunan) Co., Ltd.

articleChina Resources Double-crane Pharmaceutical Co., Ltd. Class AJuly 1, 20265/news/china-resources-double-crane-pharmaceutical-co-ltdannouncement-on-obtainment-of-cep-certificate-for-sodium-valproate-api-by-holding-subsidiary-china-resources-double-crane-pharmaceutical-hunan-co-ltd
"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtainment of CEP Certificate for Sodium Valproate API by Holding Subsidiary China Resources Double-Crane Pharmaceutical (Hunan) Co., Ltd.

About this update from China Resources Double-crane Pharmaceutical Co., Ltd. Class A

Announcement on Obtainment of CEP Certificate for Sodium Valproate API by Holding Subsidiary China Resources Double-Crane Pharmaceutical (Hunan) Co., Ltd.The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for China Resources Double-crane Pharmaceutical Co., Ltd. Class A